GGHYX — Invesco Health Care Fund
Data updated: 2026-06-26
GGHYX — Invesco Health Care Fund data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. United States Health Care Equity · $1.13B AUM · 0.82% expense ratio · 4.3% 1-yr return. From SEC regulatory filings.
GGHYX Fund Overview
GGHYX — Invesco Health Care Fund is a US mutual fund managed by Aim Investment Funds (invesco Investment Funds), categorised as United States Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Aim Investment Funds (invesco Investment Funds)
- Category: United States Health Care Equity
- Assets under management: $1.13B
- 1-year return: 4.3%
- Ticker: GGHYX
- SEC CIK: 0000826644
- SEC series ID: S000000235
- Share class ID: C000071224
GGHYX Holdings
Top 10 holdings of Invesco Health Care Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Eli Lilly and Co. | 9.65% |
| Johnson & Johnson | 5.85% |
| AstraZeneca PLC | 4.18% |
| Gilead Sciences, Inc. | 3.90% |
| UnitedHealth Group Inc. | 3.79% |
| argenx SE | 3.66% |
| AbbVie Inc. | 3.62% |
| McKesson Corp. | 3.43% |
| Cencora, Inc. | 3.12% |
| Invesco Private Prime Fund | 3.01% |
GGHYX Portfolio Allocation
Asset-class allocation of Invesco Health Care Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 97.0% |
| Cash & Equivalents | 7.0% |
GGHYX Performance
Total returns for GGHYX (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -6.4% |
| 1 year | 4.3% |
| 3 years (annualised) | 4.6% |
| 5 years (annualised) | 2.0% |
GGHYX Risk Information
Risk metrics for GGHYX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 14.5%
GGHYX Costs and Fees
GGHYX costs about $82 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.82%
- Gross expense ratio: 0.82%
- Portfolio turnover: 59%
- Brokerage commissions: 4.24 bps of average net assets (SEC N-CEN)
GGHYX Cashflows
Over the 12 months to 2026-04, Invesco Health Care Fund had net outflows of $67.87M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-04 | −$12.07M |
| 2026-03 | −$10.45M |
| 2026-02 | −$8.67M |
| 2026-01 | −$12.83M |
| 2025-12 | $33.90M |
| 2025-11 | −$5.05M |
GGHYX Debt Constituents
No individual debt constituents are reported in Invesco Health Care Fund's latest SEC N-PORT filing.
GGHYX Prospectus and SEC Filings
Official Invesco Health Care Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.